Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.860
-0.010 (-0.53%)
At close: Oct 31, 2025, 4:00 PM EST
1.860
0.00 (0.00%)
Pre-market: Nov 3, 2025, 7:00 AM EST
Edesa Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
13.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | - | - | - |
| Sep 30, 2023 | - | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | 328.80K | -82.07K | -19.97% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
EDSA News
- 2 days ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 6 days ago - Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewsWire
- 3 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire
- 6 months ago - Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewsWire
- 6 months ago - Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewsWire
- 7 months ago - Edesa Biotech Announces Chief Financial Officer Transition - GlobeNewsWire
- 9 months ago - Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewsWire
- 9 months ago - Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire